NURO
Price
$4.33
Change
-$0.05 (-1.14%)
Updated
Apr 24, 04:43 PM (EDT)
Capitalization
8.07M
SGHT
Price
$3.30
Change
+$0.09 (+2.80%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
264.12M
6 days until earnings call
Ad is loading...

NURO vs SGHT

Header iconNURO vs SGHT Comparison
Open Charts NURO vs SGHTBanner chart's image
NeuroMetrix
Price$4.33
Change-$0.05 (-1.14%)
VolumeN/A
Capitalization8.07M
Sight Sciences
Price$3.30
Change+$0.09 (+2.80%)
Volume$312
Capitalization264.12M
NURO vs SGHT Comparison Chart
Loading...
NURO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGHT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NURO vs. SGHT commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NURO is a StrongBuy and SGHT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (NURO: $4.38 vs. SGHT: $3.21)
Brand notoriety: NURO and SGHT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NURO: 3% vs. SGHT: 83%
Market capitalization -- NURO: $8.07M vs. SGHT: $264.12M
NURO [@Medical Specialties] is valued at $8.07M. SGHT’s [@Medical Specialties] market capitalization is $264.12M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NURO’s FA Score shows that 1 FA rating(s) are green whileSGHT’s FA Score has 0 green FA rating(s).

  • NURO’s FA Score: 1 green, 4 red.
  • SGHT’s FA Score: 0 green, 5 red.
According to our system of comparison, NURO is a better buy in the long-term than SGHT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NURO’s TA Score shows that 4 TA indicator(s) are bullish while SGHT’s TA Score has 5 bullish TA indicator(s).

  • NURO’s TA Score: 4 bullish, 4 bearish.
  • SGHT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both NURO and SGHT are a good buy in the short-term.

Price Growth

NURO (@Medical Specialties) experienced а +0.81% price change this week, while SGHT (@Medical Specialties) price change was +22.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

NURO is expected to report earnings on Mar 31, 2025.

SGHT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGHT($264M) has a higher market cap than NURO($8.07M). NURO YTD gains are higher at: 10.202 vs. SGHT (-9.615). NURO has higher annual earnings (EBITDA): -7.1M vs. SGHT (-49.42M). SGHT has more cash in the bank: 138M vs. NURO (18M). NURO has less debt than SGHT: NURO (241K) vs SGHT (35.4M). SGHT has higher revenues than NURO: SGHT (81.1M) vs NURO (5.9M).
NUROSGHTNURO / SGHT
Capitalization8.07M264M3%
EBITDA-7.1M-49.42M14%
Gain YTD10.202-9.615-106%
P/E RatioN/AN/A-
Revenue5.9M81.1M7%
Total Cash18M138M13%
Total Debt241K35.4M1%
FUNDAMENTALS RATINGS
NURO: Fundamental Ratings
NURO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUROSGHT
RSI
ODDS (%)
Bearish Trend 15 days ago
78%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 15 days ago
80%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 15 days ago
87%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 22 days ago
80%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 18 days ago
87%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 15 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NURO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGHT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ON39.963.34
+9.12%
ON Semiconductor Corp
OFLX31.450.97
+3.18%
Omega Flex
CRNX33.391.02
+3.15%
Crinetics Pharmaceuticals
CARV1.36N/A
+0.07%
Carver Bancorp
KRRO17.44-0.52
-2.90%
Korro Bio

NURO and

Correlation & Price change

A.I.dvisor tells us that NURO and SGHT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NURO and SGHT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURO
1D Price
Change %
NURO100%
N/A
SGHT - NURO
26%
Poorly correlated
+2.49%
NAOV - NURO
25%
Poorly correlated
-2.64%
MASI - NURO
23%
Poorly correlated
+2.98%
NVST - NURO
23%
Poorly correlated
+1.65%
DXR - NURO
23%
Poorly correlated
N/A
More

SGHT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGHT has been loosely correlated with RDNT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SGHT jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGHT
1D Price
Change %
SGHT100%
+2.49%
RDNT - SGHT
43%
Loosely correlated
+2.94%
TWST - SGHT
42%
Loosely correlated
+6.78%
HBIO - SGHT
42%
Loosely correlated
-2.06%
PACB - SGHT
41%
Loosely correlated
-2.56%
NEO - SGHT
40%
Loosely correlated
+1.82%
More